Pluri, Inc. (PLUR)
1.18
-0.06
(-4.48%)
USD |
NASDAQ |
Nov 09, 16:00
1.18
0.00 (0.00%)
After-Hours: 19:29
Pluri Profit Margin (Quarterly) : -1.85K% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.85K% |
| March 31, 2026 | -3.70K% |
| December 31, 2025 | -3.47K% |
| September 30, 2025 | -1.94K% |
| June 30, 2025 | -1.95K% |
| March 31, 2025 | -1.48K% |
| December 31, 2024 | -1.68K% |
| September 30, 2024 | -1.85K% |
| June 30, 2024 | -6.11K% |
| March 31, 2024 | -7.59K% |
| December 31, 2023 | -4.76K% |
| September 30, 2023 | -9.44K% |
| June 30, 2023 | -5.95K% |
| March 31, 2023 | -8.92K% |
| December 31, 2022 | -412.7K% |
| September 30, 2022 | -7.21K% |
| June 30, 2022 | |
| March 31, 2022 | -4.24K% |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 |
| Date | Value |
|---|---|
| March 31, 2020 | |
| December 31, 2019 | -27.70K% |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | -17.37K% |
| September 30, 2018 | -219.6K% |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | -16.46K% |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | -144.0% |
| September 30, 2015 | -6.19K% |
| June 30, 2015 | -5.63K% |
| March 31, 2015 | -7.61K% |
| December 31, 2014 | -6.57K% |
| September 30, 2014 | -6.22K% |
| June 30, 2014 | -6.59K% |
| March 31, 2014 | -9.76K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Compugen Ltd. | -269.3% |
| Evogene Ltd. | -458.5% |
| Scinai Immunotherapeutics Ltd. | -106.0% |
| CollPlant Biotechnologies Ltd. | -2.52K% |
| Regentis Biomaterials Ltd. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -82.43% |
| Return on Invested Capital | -101.2% |
| Gross Profit Margin (Quarterly) | 21.49% |
| Operating Margin (Quarterly) | -1.66K% |
| Return on Net Operating Assets | -173.3% |